Concepedia

Janneke van Wingerden

JV

Statistics

Publications

3

Citations

67

H-Index

3

Active since

2013

Affiliations

Sanofi (Netherlands)(Current)

Janneke van Wingerden is an author at Sanofi (Netherlands) specializing in pharmacotherapy, outcomes research, and multiple sclerosis therapy.

Publications per year

2013–2022

3

Publications

3

Costs of CO2 Transportation Infrastructures

Wim Mallon, Luuk Buit, Janneke van Wingerden et al. · Energy Procedia · 2013 · 31 citations · Full text

, , +13

Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry

Viktoria Papp, Mathias Due Buron, Volkert Siersma et al. · PLoS ONE · 2021 · 20 citations · Full text

, , +17

Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study

Lita Araujo, Svend Sparre Geertsen, Allen Amedume et al. · Neurology and Therapy · 2022 · 16 citations · Full text

, , +15

1–3 of 3